CDK5 phosphorylates eNOS at Ser-113 and regulates NO production

Journal of Cellular Biochemistry

Volumn 110, Issue 1, 2010, Pages 112-117

  Lee, Chien Hsing ^a   Wei, Yin Win ^b   Huang, Yi Ting ^b   Lin, Yuh Te ^a,c   Lee, Yu Cheng ^a   Lee, Kuen Haur ^a   Lu, Pei Jung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Alzheimer's diseases; Cdk5; eNOS; NO; Parkinson's diseases

Indexed keywords

CYCLIN DEPENDENT KINASE 5; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE; PROTEIN P35; SERINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 5; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; RATS;

EID: 77951721375     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22515     Document Type: Article

References (31)

1. Aguilera P, Chanez-Cardenas ME, Floriano-Sanchez E, Barrera D, Santamaria A, Sanchez-Gonzalez DJ, Perez-Severiano F, Pedraza-Chaverri J, Jimenez PD. 2007. Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease. Neurotoxicology 28:1200-1207. (Pubitemid 350026598)
2. Alderton WK, Cooper CE, Knowles RG. 2001. Nitric oxide synthases: Structure, function and inhibition. Biochem J 357:593-615. (Pubitemid 32735142)
3. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL. 2007. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117:1961-1967. (Pubitemid 47036330)
4. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G. 2005. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA 102: 904-908. (Pubitemid 40282763)
5. Camins A, Verdaguer E, Folch J, Canudas AM, Pallas M. 2006. The role of CDK5/P25formation/inhibition in neurodegeneration. Drug News Perspect 19:453-460.
6. Campese VM, Sindhu RK, Ye S, Bai Y, Vaziri ND, Jabbari B. 2007. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Res 1134:27-32. (Pubitemid 46135539)
7. Canzoniero LM, Adornetto A, Secondo A, Magi S, Dell'aversano C, Scorziello A, Amoroso S, Di Renzo G. 2006. Involvement of the nitric oxide/protein kinase G pathway in polychlorinated biphenyl-induced cell death in SH-SY 5Y neuroblastoma cells. J Neurosci Res 84:692-697.
8. Chen PF, Tsai AL, Wu KK. 1995. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun 215:1119-1129.
9. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. 1999. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289. (Pubitemid 29080812)
10. de la Monte SM, Lu BX, Sohn YK, Etienne D, Kraft J, Ganju N, Wands JR. 2000. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: Relevance to cerebral vasculopathy and neurodegeneration. Neurobiol Aging 21:309-319. (Pubitemid 30387090)
11. De Palma C, Falcone S, Panzeri C, Radice S, Bassi MT, Clementi E. 2008. Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: A link between inflammation and neuroprotection. J Neurochem 106:193-204. (Pubitemid 351840202)
12. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH. 1994. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc Natl Acad Sci USA 91:4214-4218. (Pubitemid 24143403)
13. Faraci FM. 2006. Protecting the brain with eNOS: Run for your life. Circ Res 99:1029-1030.
14. Faraci FM, Heistad DD. 1998. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 78:53-97. (Pubitemid 28070975)
15. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601. (Pubitemid 29279181)
16. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131-138. (Pubitemid 13203451)
17. Guix FX, Uribesalgo I, Coma M, Munoz FJ. 2005. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126-152. (Pubitemid 41242885)
18. Jiang W, Desjardins P, Butterworth RF. 2009. Hypothermia attenuates oxidative/nitrosative stress, encephalopathy and brain edema in acute (ischemic) liver failure. Neurochem Int 55:124-128.
19. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH. 2001. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21:6758-6771. (Pubitemid 32781119)
20. Luo S, Vacher C, Davies JE, Rubinsztein DC. 2005. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: Implications for mutant huntingtin toxicity. J Cell Biol 169:647-656. (Pubitemid 41002857)
21. Maccioni RB, Otth C, Concha II, Munoz JP. 2001. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 268:1518-1527. (Pubitemid 32862683)
22. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536. (Pubitemid 27060443)
23. Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, Kemp BE. 2002. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem 277:42344-42351. (Pubitemid 35257555)
24. Nguyen MD, Boudreau M, Kriz J, Couillard-Despres S, Kaplan DR, Julien JP. 2003. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci 23: 2131-2140. (Pubitemid 36368901)
25. Nonaka Y, Koumura A, Hyakkoku K, Shimazawa M, Yoshimura S, Iwama T, Hara H. 2009. Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone. J Pharmacol Exp Ther 330:13-22.
26. Ohshima T, Ogawa M, Takeuchi K, Takahashi S, Kulkarni AB, Mikoshiba K. 2002. Cyclin-dependent kinase 5/p35 contributes synergistically with Reelin/Dab1 to the positioning of facial branchiomotor and inferior olive neurons in the developing mouse hindbrain. J Neurosci 22: 4036-4044. (Pubitemid 37465712)
27. Shin HJ, Lee JY, Son E, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS. 2007. Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci Lett 416:49-54. (Pubitemid 46437284)
28. Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O'Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS. 2003. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 100:13650-13655. (Pubitemid 37444794)
29. Sohn YK, Ganju N, Bloch KD, Wands JR, de la Monte SM. 1999. Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 162:133-151. (Pubitemid 29125245)
30. Urano T, Ito Y, Akao M, Sawa T, Miyata K, Tabata M, Morisada T, Hato T, Yano M, Kadomatsu T, Yasunaga K, Shibata R, Murohara T, Akaike T, Tanihara H, Suda T, Oike Y. 2008. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler Thromb Vasc Biol 28:827-834.
31. Zhao YY, Zhao YD, Mirza MK, Huang JH, Potula HH, Vogel SM, Brovkovych V, Yuan JX, Wharton J, Malik AB. 2009. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 119:2009-2018.